|
|
|
市場調査レポート
アンチエイジング製品の米国市場
Anti-Aging Products to 2009
|
当商品の販売は、2011年07月19日を持ちまして終了しました。
US demand to reach $30 billion by 2009
Demand for anti-aging products is expected to reach $30 billion in 2009, propelled by a stream of new and improved products offering health maintenance and appearance enhancing benefits to a largely untapped customer base of middle-aged and elderly consumers. The value of chemicals used to manufacture these products will reach $3.8 billion.
Memory improvement, prostate care, vision care products to post most rapid gains
Astute direct-to-consumer marketing and new, more effective anti-aging pharmaceuticals and dietary supplements will promote annual gains for the large health maintenance segment. Bone and joint care products will continue to dominate the health maintenance segment, spurred by a growing customer base and a plethora of new and improved products expected to soon enter the marketplace. The most rapid gains are projected for memory improvement, vision care and prostate care products. An aging population, as well as heightened consumer awareness of Alzheimer s disease, will drive demand for memory improvement products. However, further advances will be limited by the inability of current medications to cure or reverse lost memory functions.
Demand for vision care products will be propelled by aging baby boomers that are becoming aware of debilitating eye conditions and seeking both preventative measures and ameliorative treatments. Elevated interest and willingness among aging males to maintain their health, the increased understanding of prostate care issues and the introduction of new and improved products will promote demand for prostate care products. Consumers will continue to increasingly combine the use of both pharmaceuticals and dietary supplements in their pursuit of well being. Pharmaceuticals will achieve the more rapid gains, supported by new product introductions and pricing premiums for patent-protected blockbuster drugs. Although slower, growth in dietary supplements will still be respectable.
Formulated appearance enhancing products to register strong growth
New product introductions and the passage of the relatively affluent baby boomer generation through middle age (when agerelated changes become more apparent) will stimulate demand for formulated appearance antiaging products. Strong growth will arise from various products that reduce the visibility of wrinkles and age spots, such as wrinkle removal injections and age-defying lotions. However, gains will be limited by fierce price competition among the large number of over-thecounter brands continuing to emerge. Hair growth stimulants will also record robust gains.
Chemicals expected to benefit from rapid gains in anti-aging products include memory-enhancing neurological and ophthalmic agents; botulinum toxin for wrinkle-reducing applications; and a host of small volume herbal extracts, including lutein, lycopene and black cohosh, used in both dietary supplements and cosmeceuticals.
Study coverage
These and other findings are presented in the new Freedonia industry study, Anti-Aging Products, which Historical data (1994, 1999, 2004) plus forecasts to 2009 and 2014 are provided in current dollars for major anti-aging products and chemicals. In addition, market share is provided for leading anti-aging chemical suppliers, along with an overview of competitive strategies, recent merger and acquisition activity, regulatory issues and the macroeconomy. Company profiles are provided for the major producers of anti-aging products and chemicals.
TABLE OF CONTENTS
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
- General
- Macroeconomic Outlook
- Demographic & Life Expectancy Trends
- Age-Related Health Condition Overview
- Bone & Joint
- Arthritis
- Osteoporosis
- Other
- Hair Loss
- Menopause
- Vision
- Cataracts
- Macular Degeneration
- Glaucoma
- Other Vision
- Chronic Erectile Dysfunction
- Benign Prostatic Hyperplasia
- Dementia
- Alzheimers Disease
- Other
- Cosmetic Surgery Procedures Outlook
- Cosmetic & Toiletry Industry Overview
- Pharmaceutical Industry Overview
- Nutraceutical Industry Overview
III. OVERVIEW
- Demand Overview
- Historical Market Trends
- Regulatory Factors
- Pricing Trends
- International Activity
IV. FORMULATED HEALTH MAINTENANCE PRODUCTS
- General
- Bone & Joint Care
- Pharmaceuticals
- Anti-Arthritics
- Osteoporosis Pharmaceuticals
- Supplements
- Glucosamine & Chondroitin Formulations
- Formulated Calcium Blends
- Other
- Sexual Dysfunction/Impotence
- Pharmaceuticals
- Supplements
- Menopause
- Hormone Replacement Therapy
- Supplements
- Prostate Care
- Pharmaceuticals
- Supplements
- Vision Care
- Pharmaceuticals
- Glaucoma
- Macular Degeneration & Other
- Supplements
- Memory Improvement
- Pharmaceuticals
- Supplements
- Other
V. FORMULATED APPEARANCE PRODUCTS
- General
- Aging Skin Care
- Age-Defying Lotions & Creams
- Injections
- Botulinum Toxin-Based
- Collagen
- Other
- Peels & Exfoliants
- Other
- Hair Loss
- Finasteride-Based
- Minoxidil-Based
- Other
- All Other
VI. ANTI-AGING PRODUCT CHEMICALS
- General
- Pharmaceutical Active Ingredients
- Non-Hormonal Anti-Arthritic Agents
- Ophthalmic Agents
- Neurological Agents
- Other
- Vitamins & Antioxidants
- Vitamin E
- Coenzyme Q10
- Vitamin A
- Other
- Chondroitin
- Hormones
- Estrogen
- Progesterone & Other
- Herbal Extracts
- Ginkgo Biloba
- Soy
- Ginseng
- Lycopene
- Black Cohosh
- Saw Palmetto
- Other
- Lutein
- Red Clover
- Chaste Tree
- Dong Quai
- All Other
- Glucosamine
- Minerals
- Calcium
- Other
- Proteins
- Collagen
- Amino Acids & Peptides
- Other
- Botulinum Toxin
- Other
- Hydroxy Acids
- Enzymes
- All Other
VII. INDUSTRY STRUCTURE
- General
- Anti-Aging Chemical Market Share
- Pfizer
- Merck
- Wyeth
- BASF
- Eli Lilly
- Marketing & Distribution
- Manufacturing
- Competitive Strategies
- Cooperative Agreements
- Acquisitions & Divestitures
- Research & Development
COMPANY PROFILES
- Allergan Incorporated
- Alza Corporation, see Johnson & Johnson
- Andrew Jergens Company, see Kao Corporation
- Archer-Daniels-Midland Company
- Aventis Pharmaceuticals Incorporated, see Sanofi-Aventis
- Avon Products Incorporated
- Bardeen Sciences Company LLC, see Allergan
- BASF AG
- Bayer AG
- Beiersdorf AG
- Berlex Incorporated, see Schering AG
- Boehringer Ingelheim GmbH
- Cargill Incorporated
- Cognis GmbH
- CR-1 LP, see Cargill Incorporated and DSM NV
- Croda International plc
- DSM NV
- Eastman Chemical Company
- Estee Lauder Companies Incorporated
- General Nutrition Centers Incorporated, see GNC
- GlaxoSmithKline plc
- GNC Corporation
- Hauser Technical Services Incorporated, see Integrated
- BioPharma
- Herbalife Limited
- Hoffman-La Roche Incorporated, see Roche Holding
- IHT Health Products Incorporated, see Integrated
- BioPharma
- Inamed Corporation
- InB: Hauser Pharmaceuticals Incorporated, see
- Integrated BioPharma
- Indena SpA
- Integrated BioPharma Incorporated
- Janssen Pharmaceutica Products LP, see Johnson &
- Johnson
- Johnson & Johnson
- Kaneka Corporation
- Kao Corporation
- Kyowa Hakko Kogyo Company Limited
- La Prairie Incorporated, see Beiersdorf AG
- Laboratoires Serobiologiques, see Cognis GmbH
- Lilly (Eli) and Company
- LOreal SA
- McNeil Nutritionals LLC, see Johnson & Johnson
- Merck & Company Incorporated
- Neutrogena Corporation, see Johnson & Johnson
- Novartis International AG
- NuCycle Therapy Incorporated, see Integrated BioPharma
- Oculex Pharmaceuticals Incorporated, see Allergan
- Ortho-McNeil Pharmaceutical Incorporated, see Johnson & Johnson
- OrthoNeutrogena, see Johnson & Johnson
- Personal Products Company, see Johnson & Johnson
- Pfizer Incorporated
- Procter & Gamble Company
- RoC SA, see Johnson & Johnson
- Roche Consumer Health, see Bayer AG
- Roche Holding Limited
- Royal Numico NV
- Sanofi-Aventis
- Schering AG
- Sederma SA, see Croda International plc
- SkinMedica Incorporated
- Solgar Vitamins and Herb Company Incorporated, see
- Wyeth
- Todd (AM) Group of Companies
- Triarco Industries Incorporated
- Unilever Group
- Vitamin Factory Incorporated, see Integrated BioPharma
- Wyeth
- Other Companies Mentioned in Study
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
- Summary Table
SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Demographic Trends
- 3 Selected Age-Related Medical Conditions by Type
- 4 Cosmetic & Toiletry Supply & Demand
- 5 Pharmaceutical Supply & Demand by Type
- 6 Nutraceutical Supply & Demand
SECTION III -- OVERVIEW
- 1 Formulated Anti-Aging Product Demand
- 2 Formulated Anti-Aging Product Market Trends, 1994-2004
- 3 Selected Anti-Aging Chemical Prices
SECTION IV -- FORMULATED HEALTH MAINTENANCE PRODUCTS
- 1 Formulated Health Maintenance Anti-Aging Product Demand
- 2 Bone & Joint Care: Anti-Aging Product Demand
- 3 Sexual Dysfunction/Impotence: Anti-Aging Product Demand
- 4 Menopause Product Demand
- 5 Prostate Care Product Demand
- 6 Vision Care: Anti-Aging Product Demand
- 7 Memory Improvement: Anti-Aging Product Demand
- 8 Other Anti-Aging Health Maintenance Product Demand
SECTION V -- FORMULATED APPEARANCE PRODUCTS
- 1 Formulated Appearance Product Demand
- 2 Aging Skin Care Product Demand
- 3 Age-Defying Lotions & Creams Demand
- 4 Wrinkle Removal Injection Demand
- 5 Peels & Exfoliants: Anti-Aging Product Demand
- 6 Other Anti-Aging Skin Product Demand
- 7 Hair Loss: Anti-Aging Product Demand
- 8 Other Anti-Aging Appearance Product Demand
-
SECTION VI -- ANTI-AGING PRODUCT CHEMICALS
- 1 Anti-Aging Product Chemical Demand
- 2 Pharmaceutical Active Ingredients: Anti-Aging
- Product Applications
- 3 Vitamins & Antioxidants: Anti-Aging Product Applications
- 4 Chondroitin: Anti-Aging Product Applications
- 5 Hormones: Anti-Aging Product Applications
- 6 Herbal Extracts: Anti-Aging Product Applications
- 7 Glucosamine: Anti-Aging Product Applications
- 8 Minerals: Anti-Aging Product Applications
- 9 Proteins: Anti-Aging Product Applications
- 10 Botulinum Toxin: Anti-Aging Product Applications
- 11 Other Anti-Aging Chemical Demand
SECTION VII -- INDUSTRY STRUCTURE
- 1 US Anti-Aging Chemical Sales by Company, 2004
- 2 Selected Cooperative Agreements
- 3 Selected Acquisitions & Divestitures
- 4 R & D Spending Patterns: Selected Anti-Aging Product & Chemical Suppliers
LIST OF CHARTS
SECTION III -- OVERVIEW
- 1 Formulated Anti-Aging Product Demand Per Capita 50+, 1994-2004
- 2 World Formulated Anti-Aging Product Demand, 2004
SECTION IV -- FORMULATED HEALTH MAINTENANCE PRODUCTS
- 1 Formulated Health Maintenance Anti-Aging Product Demand by Type, 2004
SECTION V -- FORMULATED APPEARANCE PRODUCTS
- 1 Formulated Appearance Product Demand by Type, 2004
SECTION VI -- ANTI-AGING PRODUCT CHEMICALS
- 1 Anti-Aging Product Chemical Demand by Type, 2004
SECTION VII -- INDUSTRY STRUCTURE
- 1 US Anti-Aging Chemical Market Share, 2004
|
 |
